| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 197.41 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Medical ethicists have questioned the use of no-treatment controlled studies (placebo and sham procedure) of new therapies
when safe and effective standard therapies are available for use as an active or “equivalence” control. Currently, ethical and
conduct principles for biomedical research specifically prohibit projects that do not make or deny the “best-proven diagnosis
and therapeutic treatment” to any participant in a clinical trial, including individuals who consent to randomisation into a control
group. Studies of psychophysiological therapies are often criticised for not having a placebo or sham treatment control group.
In sports science research, particularly in the case of clinical exercise, the use of control groups also raises ethical questions. This
article briefly reviews the problem and discusses the ethical standards governing human research derived from the Nuremberg
Code and the Declaration of Helsinki.
Descrição
Palavras-chave
Ethics of control group Placebo control Randomised controlled trial Clinical exercise Research Subject Categories::INTERDISCIPLINARY RESEARCH AREAS::Sports
Contexto Educativo
Citação
Louro, Gonçalo; Ferraz, Ricardo; Forte, Pedro; Teixeira, José Eduardo; Branquinho, Luís; Esteves, Dulce (2023). The use of control group in the sports science research: the ethical challenge. Motricidade. ISSN 1646-107X. 19:1, p. 4-11
Editora
University of Tras-os-Montes and Alto Douro